Chen Lao was born in a family of traditional Chinese medicine and studied under Chen Shi 'an, a famous Chinese medicine expert in Beijing. He has rich theoretical and practical knowledge, especially in andrology and internal medicine. He is good at studying male diseases such as male infertility, male sexual dysfunction and prostate diseases, as well as asthma, diabetes, kidney disease, liver disease and senile diseases. More than 30 series of traditional Chinese medicine formulations, such as Shengjing Zanyu Pill and Asthma Liniment, were developed and made into various dosage forms, with remarkable clinical effects. Invited to give lectures at home and abroad for many times; Patrol. He was highly praised by foreign experts during his lectures in the United States and Japan.
Over the past decades, more than 0/00 high-level scientific research papers have been published, including more than 0/00 academic monographs, such as Outline of Syndrome and Treatment of Male Infertility, Applied China Andrology, New Theory of Andrology and Male Sexual Dysfunction. Many of his research achievements won the National Invention Patent and the Beijing Science and Technology Progress Award respectively, and one of them was selected as "Selected Scientific and Technological Achievements of China in the Eighth Five-Year Plan". In order to make the cause of Chinese medicine successful. He set an example and brought five formal disciples, all of whom have now become the young backbone of andrology in traditional Chinese medicine.
Because of Chen Wenbo's superb medical skills, noble medical ethics and profound academic attainments, he has been re-elected as the main leader of the national andrology academic group of traditional Chinese medicine for many times in the past 20 years. He is recognized as a famous academic leader in andrology of traditional Chinese medicine in China, enjoying high prestige and reputation at home and abroad, and has made outstanding contributions to the development of andrology of traditional Chinese medicine.